This FOA invites applications for funding of infrastructure of a screening and clinical activities coordination unit, the Type 1 Diabetes TrialNet Clinical Network Hub (CNH). The main objective is to increase the efficiency of risk screening, pilot new and creative approaches to screening, recruitment, and trial implementation, and increase the operational efficiency and flexibility of the TrialNet network. The addition of a new TrialNet unit, the CNH, provides an opportunity for restructuring TrialNet’s organizational leadership to increase efficiency and optimize responsive decision-making.
Admin/Reviewer Login here first
Back to the WINS main page